Med sales in Egypt increased by 25% to EGP 50 bn in 2016, Federation of Egyptian Chambers of Commerce’s pharma division chief Ali Auf said on Saturday, Al Mal reports. Recent government-sanctioned price hikes to meds are being credited with the jump in sales and are expected to drive further growth in sales this year to around EGP 65 bn, according to Auf.
More from Enterprise
Central Bank of Egypt looks to renew USD 2 bn Kuwaiti deposit as regional conflict stalls FDI conversions
The maturing USD 2 bn deposit is expected to be…
Miga guarantee unlocks USD 313 mn for National Bank of Egypt trade finance
Plus: Incolease taps securitization market with debut EGP 2 bn…
Ceasefire optimism triggers EGX30 rally and EGP recovery
The EGP gained around 2.5% on the greenback by the…
IBF & Company doubles down on logistics with Techno Metal acquisition
Plus: Lucky lands USD 23 mn in Series B round,…